EGFR and colonic neoplasm: Using colon cancer tissues as a substrate for combined IHC and molecular analysis (FISH and PCR), a recently published study showed that EGFR copy number and non-protein overexpression is linked with prognosis and patients demonstrated this specific gene deregulation mechanism probably earn survival benefits, responding to monoclonal antibody treatment (Moroni et al. 2005).